• Health & Medicine

Kidney cancer drug gets initial ‘no’ for the NHS in England

A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England

17 February 2020

• Science & Technology

New technique allows scientists to 'listen in' on cancer cells

Scientists have a developed a new technique to decipher how millions of cells are communicating with each other in miniature tumours grown in the lab. Scientists have a developed a new technique to decipher how millions of cells are communicating with each other in miniature tumours grown in the lab.

17 February 2020

• Health & Medicine

Two skin cancer treatments get the green light for NHS Scotland

An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC).  An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC). 

12 February 2020

• Health & Medicine

Targeted lung cancer treatment gets initial ‘no’ for NHS in England

Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua).  Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua). 

4 February 2020

• Health & Medicine

Never too late to quit: protective cells could cut risk of lung cancer for ex-smokers

Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer. Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer.

29 January 2020

• Health & Medicine

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England. Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

23 January 2020

• Health & Medicine

Cervical cancer progress falters as screening uptake hits record lows

Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating. Cervical cancer rates in Britain halved between the late 1980s and mid-2000s - but new CRUK figures warn that progress has since been stalling and stagnating.

22 January 2020

• Science & Technology

Magnetised molecules used to monitor breast cancer

Scientists have tested a new type of scan, which reveals how aggressive a tumour is, for the first time in patients with breast cancer. Scientists have tested a new type of scan, which reveals how aggressive a tumour is, for the first time in patients with breast cancer.

20 January 2020

• Health & Medicine

Hormone therapy now available for newly diagnosed prostate cancer in Scotland 

A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.   A hormone therapy has been approved for NHS use in Scotland for some people with newly diagnosed, advanced prostate cancer for the first time.  

20 January 2020

• Health & Medicine

Lung cancer immunotherapy gets initial ‘no’ for NHS in England

An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England. An immunotherapy and chemotherapy combo has been rejected for some adults with small cell lung cancer on the NHS in England.

8 January 2020

• Health & Medicine

Complex innovative trials: Authors call for new guideline adoption to get medicines to patients faster

Complex Innovative Design trials could be transformed for the better, following the publication of ten recommendations in the British Journal of Cancer. Complex Innovative Design trials could be transformed for the better, following the publication of ten recommendations in the British Journal of Cancer.

6 January 2020

• Health & Medicine

Artificial intelligence could help breast screening save more lives

We’ve helped Google Health with AI research which has the potential to improve breast cancer screening and save the NHS time and money. We’ve helped Google Health with AI research which has the potential to improve breast cancer screening and save the NHS time and money.

1 January 2020